Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell Disease

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Sickle Cell Disease
Interventions
OTHER

Cardiac echography

Ejection fraction measured by Teicholz and planimetry, diastolic function, tissular doppler, myocardiac performance index, global longitudinal strain measured by speckle tracking, arterial pulmonary hypertension, left ventricular hypertrophy.

OTHER

Biological parameters

Hemoglobin levels, red cells, hematocrit, iron, ferritin

OTHER

Clinical parameters

Blood transfusion number, severity of the sickle cell disease damage, evolution duration of the sickness

Trial Locations (1)

1020

CHU Brugmann, Brussels

All Listed Sponsors
lead

Brugmann University Hospital

OTHER

NCT02394431 - Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell Disease | Biotech Hunter | Biotech Hunter